Harrow, Inc. engages in the development, production, and sale of innovative medications. It operates through the following segments: Pharmaceutical Compounding and Pharmaceutical Drug Development. The Pharmaceutical Compounding segment focuses on the operations of the ImprimisRx business. The company was founded by Mark L. Baum and Robert J. Kammer in January 2006 and is headquartered in Nashville, TN.
Show more...
FAQ
Harrow Health 8.625% Senior Notes due 2026 今天的股价是多少?▼
HROWL 当前价格为 $25.61 USD,过去 24 小时上涨了 +0.19%。在图表上更密切关注 Harrow Health 8.625% Senior Notes due 2026 股价表现。
Harrow Health 8.625% Senior Notes due 2026 的股票代码是什么?▼
根据交易所不同,股票代码可能会有所不同。例如,在 交易所,Harrow Health 8.625% Senior Notes due 2026 的股票以代码 HROWL 进行交易。
Harrow Health 8.625% Senior Notes due 2026 的股价在上涨吗?▼
HROWL 股票较上周上涨 +0%,本月上涨 +0%,过去一年 Harrow Health 8.625% Senior Notes due 2026 上涨 +1.31%。
Harrow Health 8.625% Senior Notes due 2026 去年的营收是多少?▼
Harrow Health 8.625% Senior Notes due 2026 去年的营收为 199.61MUSD。
Harrow Health 8.625% Senior Notes due 2026 去年的净利润是多少?▼
HROWL 去年的净收益为 -17.48MUSD。
Harrow Health 8.625% Senior Notes due 2026 会发放股息吗?▼
是的,HROWL 的股息每 每季度 发放一次。每股最新股息为 0.54 USD。截至今日,股息率(FWD)% 为 8.42%。
Harrow Health 8.625% Senior Notes due 2026 有多少名员工?▼
截至四月 06, 2026,公司共有217名员工。
Harrow Health 8.625% Senior Notes due 2026 属于哪个行业?▼
Harrow Health 8.625% Senior Notes due 2026从事于Health Care行业。
Harrow Health 8.625% Senior Notes due 2026 何时完成拆股?▼
Harrow Health 8.625% Senior Notes due 2026 最近没有进行任何拆股。